Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Description:** Rehydragel is a highly purified, crystalline aluminum oxyhydroxide (mineralogically known as boehmite) formulated as a hydrated gel and used primarily as an adjuvant in human and veterinary vaccines[1][2][7]. It is designed to enhance the immune response by adsorbing protein antigens, thereby increasing their immunogenicity when administered with vaccines. The product has a positive charge at physiological pH, making it especially effective for binding negatively charged proteins[1]. Its high surface area (~525 m²/g) and customizable Al₂O₃ content (typically 2–10%) allow for tailored rheological properties and protein adsorption capacity[1][8]. Rehydragel does not generally induce cell-mediated immunity but promotes T-helper-2 responses with enhanced IgG1 and IgE production[2]. It is also used in blood plasma protein separation processes due to its strong protein-binding characteristics[4]. **Mechanism of Action:** As an aluminum-based adjuvant, Rehydragel works by adsorbing antigens onto its surface, facilitating their uptake by antigen-presenting cells and stimulating the humoral immune response through Th2 pathway activation. **Primary Indications:** - Adjuvant in human vaccines (e.g., HPV, pneumococcal, influenza) - Veterinary vaccine adjuvant (e.g., rabies, poultry vaccines) - Blood plasma protein separation for therapeutic applications[1][7]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Rehydragel.